METTL17

METTL17 is a mitochondria-localized, SAM-binding protein that supports assembly and function of the mitoribosomal small subunit and thereby enables translation of mitochondrially-encoded OXPHOS components (PMID:31487196, PMID:38199006). It is imported via an N-terminal targeting sequence, binds 12S mt-rRNA and small-subunit mitoribosomal proteins during late assembly, and its loss destabilizes 12S mt-rRNA and associated proteins, impairing mitochondrial translation and oxidative phosphorylation in a SAM-binding-dependent manner (PMID:31487196). METTL17 loss reduces the m4C840 and m5C842 modifications on 12S mt-rRNA, identifying it as the first known regulator of m4C840, although a dedicated test of direct methyltransferase activity on the 12S region did not confirm catalysis, indicating it may govern these marks indirectly (PMID:31487196, PMID:38234605). METTL17 harbors a [Fe4S4]2+ cluster required for its own stability and functions as an Fe-S cluster checkpoint that licenses translation of Fe-S-rich OXPHOS proteins only when Fe-S cofactors are available; its overexpression rescues mitochondrial translation and bioenergetic defects in frataxin-deficient cells (PMID:38199006). Across the assembly pathway METTL17 binds the mt-SSU early and serves as a platform for Mettl15 recruitment before being released to permit progression of pre-mitoribosome maturation [PMID:bio_10.1101_2024.12.18.629302]. METTL17 abundance is set post-translationally by a SIRT5–RNF126 axis, in which SIRT5 desuccinylates K274 to facilitate RNF126-mediated K116 ubiquitination and degradation, tuning OXPHOS output (PMID:42021405).

1. 2019 High

   Established METTL17 as a mitochondrial SAM-binding factor required for small-subunit mitoribosome integrity, answering whether it has any role in mitochondrial gene expression.

   Evidence CRISPR knockout, subcellular fractionation, RNA-protein binding, SAM-binding and quantitative rRNA modification mapping, mitochondrial translation assays in human cells

   PMID:31487196

   Open questions at the time

   • Did not demonstrate direct catalytic deposition of m4C840/m5C842 by METTL17
   • Stoichiometry and structural basis of mt-SSU binding not defined
2. 2023 Low

   Tested whether METTL17 is itself the methyltransferase for the 12S rRNA marks, addressing the catalytic-versus-regulatory question.

   Evidence MALDI-TOF mass spectrometry of a putative 12S rRNA substrate region

   PMID:38234605

   Open questions at the time

   • Negative/ambiguous result under single set of conditions; does not exclude activity in other contexts or with cofactors
   • No identification of the responsible enzyme if METTL17 is non-catalytic
3. 2024 High

   Revealed that METTL17 carries an Fe-S cluster and acts as a checkpoint coupling Fe-S availability to OXPHOS protein translation, explaining how its stability and function are cofactor-gated.

   Evidence Quantitative proteomics, sequence analysis, mutagenesis, cryo-EM, and overexpression rescue in FXN-deficient cells

   PMID:38199006

   Open questions at the time

   • Mechanism by which Fe-S occupancy is sensed and transmitted to translation not fully resolved
   • How the checkpoint discriminates Fe-S-rich transcripts not defined
4. 2024 Medium

   Linked METTL17-dependent mitochondrial RNA methylation to redox homeostasis and ferroptosis sensitivity in cancer cells, extending its role beyond bioenergetics.

   Evidence Knockdown, epitranscriptomic profiling, ROS/lipid peroxidation assays, xenograft and AOM/DSS CRC models

   PMID:38377789

   Open questions at the time

   • Direct versus indirect basis for the broad m4C/m5C/m3C/m7G/m6A changes not established
   • Causal chain from translation defect to ferroptosis not dissected
5. 2025 Medium

   Defined a post-translational control circuit (SIRT5 desuccinylation of K274 enabling RNF126 ubiquitination of K116) that sets METTL17 levels and downstream ETC component expression.

   Evidence Reciprocal Co-IP, mass spectrometry, site-directed mutagenesis, bioenergetic assays, and xenografts; single lab

   PMID:42021405

   Open questions at the time

   • Physiological signals that regulate SIRT5/RNF126 activity toward METTL17 unknown
   • Whether degradation is coordinated with the Fe-S checkpoint not addressed
6. 2025 Medium

   Provided a structural mechanism placing METTL17 as an early-assembly platform for Mettl15 recruitment, integrating early and late pre-mitoribosome maturation.

   Evidence Cryo-EM (T. brucei) and molecular dynamics integrated with mammalian homolog data (preprint)

   PMID:bio_10.1101_2024.12.18.629302

   Open questions at the time

   • Preprint, not yet peer-reviewed
   • Trigger for METTL17 release and conservation of the exact choreography in humans not confirmed
7. 2025 Low

   Reported extramitochondrial associations of METTL17 with STAT1 mRNA methylation and JAK/STAT signaling in immune and cancer contexts.

   Evidence MeRIP, knockdown, flow cytometry, docking, and xenograft models

   PMID:39957595 PMID:41005192

   Open questions at the time

   • No site-specific modification mapping or rescue; mechanistic link to the mitoribosomal function not established
   • Pathway placement inferred from downstream markers

• Whether METTL17 itself deposits the 12S mt-rRNA marks or acts purely as a scaffold/checkpoint, and how its Fe-S sensing is mechanistically coupled to translational licensing, remains unresolved.
• Direct catalytic activity unconfirmed
• Sensing-to-translation transduction mechanism undefined
• Reconciliation of mitochondrial role with reported cytoplasmic mRNA-methylation claims missing